Schedule 

[Thursday, December 1] [Friday, December 2] [ Saturday, December 3] [ Sunday, December 4] [ Monday, December 5] [ Poster list 2022]

Thursday, December 1 

1:30 pm-4:30 pm

Complex Family Planning Fellowship Directors meeting
Invitation only

4:30 pm-6:00 pm

Emerging Scholars reception
Invitation only

 [Back to top]

Friday, December 2 

7:30 am-3:30 pm

Society of Family Planning Board meeting
Invitation only

Pre-conference skills building workshops

9:00 am-12:00 pm

Mentoring 101: How to get what you need to thrive in the academy
Invitation only

(includes breakfast)

In this workshop, we challenge the conventional wisdom about mentoring and present a framework for re-imagining mentoring with the goal of helping faculty thrive in the academy. Participants will map their current mentoring network, identify pressing areas of unmet needs, and create a plan to expand their existing mentoring network.

8:00 am-4:00 pm

Breaking the silos
Invitation only

9:00 am-12:00 pm

Medically complex pregnancies meeting

The current abortion ban landscape in the United States has created an "acute-on-chronic exacerbation" of ongoing inequities in access to abortion care for pregnant people. People with medically-complex pregnancies are forced to travel great distances to obtain abortion care. Subsequently, providers are faced with challenges on how to best care for patients with complex pregnancies safely and effectively; part of this calculus includes whether certain individuals should undergo hospital-based abortions or if they can be safely cared for in the outpatient setting. This session aims to bring abortion providers from across the country together as a preliminary working group.

Registered attendees can RSVP with the organizers here.

12:00 pm-4:00 pm

Family planning billing and finance workshop
(includes lunch)


Learn and practice in this interactive billing and finance workshop tailored to family planning care. Attendees apply this knowledge through diagnostic and procedural coding in basic and complex scenarios. The engaged audience member will leave with a greater understanding of the revenue cycle and tools for establishing a cash package.

12:00 pm-4:00 pm

Level up your advocacy: Testimony training
(includes lunch)


Providers are essential voices as policymakers consider action to promote reproductive health and measures that restrict access. Learn from providers who have testified at the federal and state levels, in person and virtually. Practice writing statements, using pivots, handling tough questions, and learn how to find opportunities to testify.

12:00 pm-4:00 pm

Intersectional mentoring: An interactive exploration of institutional racism, power, and positionality for mentors
(includes lunch)


We will demonstrate the importance of an intersectional lens and a racially literate analysis of the barriers and the escalators to leadership for URiMs/ BIPOC. We will highlight the impact mentors can have when they use their social capital to advance equity in family planning with novel frameworks.

12:00 pm-4:00 pm

Social science on abortion in the wake of the Dobbs ruling: A working session
(includes lunch)


In the aftermath of the Dobbs v Jackson Women’s Health Organization ruling, people across the US will continue to need abortion care. Researchers will continue to work as a community to take action for just and equitable abortion, informed by science. This pre-conference session aims to cultivate coordination between ongoing research efforts and share tools and approaches with the awareness that research practice must transform in response to seismic shifts in the US legal abortion landscape. Organized around three entry points for discussion—methodology, outcomes, and geographic patterns—the session will use mini-panels as a springboard for discussion, with the opportunity to connect with other social science researchers in focused roundtables.

12:00 pm-4:00 pm

Ryan Residency Training Program meeting
Invitation only

1:00 pm-4:00 pm

Youth Reproductive Equity post-Roe Meeting
Open to current YRE members

This pre-conference meeting will allow the Youth Reproductive Equity group to assemble in person for the first time ever and work together on several of our many ongoing projects, which include data collection, grant writing, media appearances and commentaries, advocacy activities, and planning an upcoming year-long convening to create the Research Roadmap for Policy-Ready Research for Youth Abortion Access, modeled on the CECA Roadmap for Policy-Ready Research on Contraception. This group focuses on young people, a group whose access to abortion and contraception is constrained by systems of oppression including adultism (discrimination against young people) in addition to racism, anti-LGBTQ actions, and other identity/status-based discriminations. Our primary goal is to articulate and communicate the specific implications for adolescents of recent changes in the abortion access landscape.

Plenary

4:30 pm-4:40 pm

Opening panel

4:40 pm-5:45 pm

Reckoning with the truth: Reclaiming the history of gynecology

This plenary will bring together research, clinical, and creative presenters to grapple with systemic racism in healthcare and how it has influenced the narrative around the history of gynecology. The audience will deepen their understanding of injustices past and present, engaging with the panel through stories, video, research, and panel discussion.

5:45 pm-7:15 pm

Opening reception

6:00 pm-7:30 pm

Over-The-Counter Medication Abortion Advisory Committee meeting
Invitation only

[Back to top]

Saturday, December 3

9:00 am-9:30 am

President’s welcome

Plenary

9:30 am-10:45 am

Medically complex pregnancies and abortion bans - Lessons from Texas

This interactive panel will discuss challenges caring for people with medically complex pregnancies in the context of gestational duration bans on abortion. Panelists will identify barriers and successful strategies to providing care in the context of highly restrictive settings.

11:00 am-12:00 pm

Spotlight on science

  • An updated assessment of clinical outcomes of medication abortion without pretreatment ultrasonography 

  • Prevalent but not inevitable: Mapping contraception deserts across the American states 

  • Safety and effectiveness of synchronous and asynchronous telehealth medication abortion provided by US virtual clinics 

  • Abortion patients' priorities and tradeoffs deciding where to obtain out-of-state care following Texas 2021 abortion ban 

12:00 pm-1:15 pm

Lunch on your own

12:00 pm-1:15 pm

Ask a lawyer office hours

Stop by during these open office hours for an informal discussion with legal experts from the Lawyering Project and Resources for Abortion Delivery. Learn about the new initiative to connect everyone in the field with legal representation related to providing, obtaining, or supporting abortion access. While no legal advice can be provided during this session, we can connect you with resources if you do need advice.

12:05 pm-1:05 pm

Special Interest Group lunches
These lunches are capacity limited and currently filled. Registered attendees may join the waitlist here

  • Adolescent sexual and reproductive health

  • Advocacy 

  • Medical educators

  • Telehealth practitioners

12:05 pm-1:05 pm

AANHPI Sub-Special Interest Group meeting

Inaugural launch of the AANHPI sub-SIG, under SFP’s BIPOC SIG, as a place to share experiences and challenges in AANHPI reproductive health, and to identify and develop resource networks for research and mentorship. Will feature a roundtable discussion of urgent issues and needs of the communities, as well as opportunities to shape the future direction of the sub-SIG.

Registered attendees can RSVP with the organizers here.

Concurrent block I

1:15 pm-2:15 pm

Oral abstract group one

  • Trauma Responsive Abortion Care (On TRAC Study): The abortion experiences of patients with a history of trauma

  • The association between self-managed abortion and abortion complications: A national cross-sectional analysis in India 

  • Punished with pregnancy: Incarcerated pregnant individuals perspectives on abortion access and decision-making in custody

  • Immediate postpartum contraceptive implant placement and breastfeeding success in women at risk for low milk supply: A randomized non-inferiority trial 

1:15 pm-2:15 pm

In this together: New tools to support community engagement in SRH research

In this session, the Research Implementation Special Interest Group launches a guidance and resource document to support community-engaged sexual and reproductive health research. The guide authors will share the key content from the guide and facilitate a robust, attendee-fueled discussion about community engagement in action. Bring your lessons learned!

1:15 pm-2:15 pm

Vasectomy: An underutilized contraception

Best practices in vasectomy and the changing demographics of utilization. Suggestions to increase uptake and training in vasectomy provision.

1:15 pm-2:15 pm

Pregnancy prevention and abortion care for transgender and gender nonbinary individuals: A 2022 update

In this session, we will discuss ways to take an affirming reproductive history and review the updated literature surrounding contraception and TGNB care. We will also discuss how various contraceptive methods and abortion options may uniquely impact TGNB patients, as well as ways to reduce challenges and barriers faced in accessing those services. Lastly, we will discuss the reproductive healthcare climate in the US for this population now that Roe is overturned.

1:15 pm-2:15 pm

Health, legal, and economic consequences of the end of Roe

This panel presents the initial results of a study documenting who was turned away from abortion services after Roe. We present data on who was turned away from receiving care, their pregnancy outcomes and the consequences for their health, legal vulnerability and economic wellbeing.

2:15 pm-2:45 pm

Networking break with exhibitors 

Concurrent block II

2:45 pm-3:45 pm

Oral abstract group two

  • Cabergoline for lactation inhibition after second-trimester abortion or loss: A randomized controlled trial 

  • Barriers to abortion access for young southerners: A qualitative analysis of case notes from ARC-Southeast 

  • Trends in copper versus hormonal intrauterine device breakage reporting within the US Food and Drug Administration Adverse Event Reporting System 

  • Prevalence of self-managed abortion among US women of reproductive age: New and expanded estimates from 2021/2022 

2:45 pm-3:45 pm

Promoting the reproductive autonomy of individuals with disabilities

This session will define challenges that individuals with disabilities encounter when pursuing reproductive healthcare. It will examine the history of reproductive coercion against individuals with disabilities and will review their unique healthcare considerations. We will focus on the role of sexual education and contraceptive counseling in promoting their reproductive autonomy.

2:45 pm-3:45 pm

Pregnancy options counseling with adolescents: A multidisciplinary evidence-based approach

This workshop will address evidence-based practices for pregnancy options counseling with adolescent patients, including challenging scenarios encountered in clinical practice. The workshop will include a brief interactive didactic session followed by a facilitated discussion of cases in pregnancy options counseling with adolescent patients.

2:45 pm-3:45 pm

First they came for abortion, now they're coming for birth control

Attacks on reproductive choice are increasing at the state and federal level, and birth control is not exempt. This panel will convene state and federal policy makers and advocates to review the attacks politicians are making on birth control, and to consider ways we can protect access to birth control.

2:45 pm-3:45 pm

Abortion care while pregnant and parenting: Exploring the provider experience

Many abortion providers will experience pregnancy and parenthood. This paired experience can be both rewarding and complicated. Panelists will discuss their own varied experiences with providing abortion care while pregnant/parenting, and will create a space for attendees to share their own experiences and strategies for coping with complex emotions.

3:45 pm-4:15 pm

Snack break with exhibitors

Plenary

4:15 pm-5:30 pm

Hablamos español: Why language and culture matter in family planning education

Drawing on data from PPFA's Spanish digital education products, this session will explore trends and main themes around the types of family planning-related information that monolingual Spanish speakers seek, discuss the importance of providing reproductive health education that is linguistically and culturally relevant, and share lessons learned from this work.

5:30 pm-7:00 pm

Poster reception

6:30 pm-8:00 pm

Changemakers in Family Planning reception
Invitation only

 [Back to top]

Sunday, December 4

7:00 am-8:45 am

RISE program breakfast
Invitation only

7:45 am-8:45 am

Complex Family Planning fellows research spotlight

  • Ketamine versus fentanyl for surgical abortions: a randomized noninferiority trial 

  • The essential role of the primary obstetrician for patients seeking abortion care for fetal diagnoses in hostile settings 

  • Disparities between patients choosing video or telephone for contraceptive counseling via telehealth 

  • Emergency department staff perspectives on caring for patients experiencing early pregnancy loss

7:50 am-9:00 am

Society of Family Planning Diversity, Equity, and Inclusion Committee breakfast
Invitation only

8:00 am-9:00 am

Ask a lawyer office hours

Stop by during these open office hours for an informal discussion with legal experts from the Lawyering Project and Resources for Abortion Delivery. Learn about the new initiative to connect everyone in the field with legal representation related to providing, obtaining, or supporting abortion access. While no legal advice can be provided during this session, we can connect you with resources if you do need advice.

Plenary

9:00 am-10:15 am 

Late-breaking news: Mifepristone REMS and legal strategy to protect mifepristone

This session describes the proposal for the new mifepristone REMS and a novel legal strategy to protect mifepristone. Both the new REMS and the legal strategy, based on the Constitution that holds Federal law preempts state law, have profound implications for access to medication abortion. There will also be discussion on the importance of adopting precise and accurate terminology for the models of medication abortion.

10:15 am-10:45 am 

Networking break with exhibitors 

Concurrent block III

10:45 am-11:45 am 

Oral abstract group three

  • Contraceptive failure rates: New estimates for individual methods and method combinations 

  • The impact of the Texas abortion ban on gestational age at time of abortion in a large volume Colorado clinic

  • Abortion criminalization during Roe: Investigations and arrests for self-managed abortion from 2000- 2020

  • Self-managed abortion outcomes for pregnancies of 9-22 weeks gestation: Results from a prospective, observational study in three countries 

10:45 am-11:45 am 

Can Mexico help close the gap in access to abortion in a post-Roe world

Media reports in the US have suggested that Mexico can serve as a safety valve for US abortion access. We argue that Mexico is not a solution to the SCOTUS abdication of human rights protections, while uplifting innovative work being done in Mexico for all those who need abortion.

10:45 am-11:45 am 

Past as prologue: Using the history of family planning to inform our path forward

This panel will provide a brief history of family planning research and programming, population control, and opposition movements. Researchers and clinicians will engage in this shared history, offer opportunities for combating these undercurrents in our daily work, and discuss what lies ahead following the Dobbs v. JWHO decision.

10:45 am-11:45 am 

What about previable prelabor rupture of membranes?

Previable prelabor rupture of membranes (PPROM) can be associated with maternal morbidity and mortality. Despite these risks PPROM management varies depending on institution and location. This session examines the clinical, ethical, and legal implications of PPROM in the setting of restrictive abortion policies from both a domestic and international perspective.

10:45 am-11:45 am 

Centering perspectives of communities of color and Indigenous communities to make birth control pills OTC

Reproductive health and justice organizations, involved in a coalition-driven effort to make birth control pills over the counter in the US, have taken a community-engaged approach to center the voices of people of color and Indigenous peoples. This panel will discuss study findings and the coalition's approach.

11:45 am-12:15 pm

Networking break with exhibitors

Concurrent block IV

12:15 pm-1:15 pm

Oral abstract group four

  • Characteristics of people obtaining abortions in states likely to ban it: Findings from a 2021-2022 national study

  • Self-determination of eligibility for early medication abortion without ultrasound using a history-based tool - LMP-SURE 

  • Pregnancy and abortion: A longitudinal study of the predictive ability of people's desire to avoid pregnancy 

  • Experiences of racial/ethnic discrimination and contraceptive use: A longitudinal study

12:15 pm-1:15 pm

The ABCs of APC abortion expansion: Experiences of advanced practice clinician training in abortion care

This multidisciplinary panel presents their experiences training advanced practice clinicians (APCs) to provide procedural and medication abortion care in states that have removed physician-only restrictions. Panelists reflect on successes and challenges in advocating for APC abortion provision and developing training programs. Strategies to build training capacity will be discussed.

12:15 pm-1:15 pm

Ensuring adolescent representation in sexual and reproductive health research: Practical strategies for success

Adolescents are underrepresented in sexual and reproductive health research, despite facing sexual and reproductive health inequities. This session aims to increase awareness of unique barriers that adolescents under 18 face as potential research participants and to equip attendees with skills to include more adolescents in sexual and reproductive health research.

12:15 pm-1:15 pm

Statewide contraceptive access initiatives: Advancing the evidence for equitable contraceptive care and policy

Contraceptive access initiatives promise to advance person-centered contraceptive care and outcomes. Three initiatives implemented in the states of Delaware, South Carolina, and Utah are presented including key interventions and evaluation findings to-date. Research gaps are identified, and strategies for supporting evidence-based policy and programs are formulated.

12:15 pm-1:15 pm

What do state legislators need from researchers going into 2023?

The fight for reproductive health, rights, and justice will be at the state level in 2023. This panel of state legislators from hostile, expanded access, and in-between states will share what they need from the research community to move proactive policy and push back on restrictions in your state and beyond.

1:15 pm-2:30 pm

Lunch on your own

1:15 pm-2:30 pm

Ask a lawyer office hours

Stop by during these open office hours for an informal discussion with legal experts from the Lawyering Project and Resources for Abortion Delivery. Learn about the new initiative to connect everyone in the field with legal representation related to providing, obtaining, or supporting abortion access. While no legal advice can be provided during this session, we can connect you with resources if you do need advice.

CooperSurgical Symposium

1:20 pm- 2:20 pm

Menstrual Cycle Changes with Long-Acting Reversible Contraceptives (LARCs)
Sponsored by CooperSurgical

Click here for more information
Unaccredited session

1:20 pm-2:20 pm

Special Interest Group lunches
These lunches are capacity limited and currently filled. Registered attendees may join the waitlist
 here

  • Black, Indigenous, and people of color

  • Early pregnancy assessment clinics

  • Family medicine

  • Research implementation

  • Substance use disorders

Plenary

2:30 pm-3:45 pm 

Patient confidentiality is an RJ issue: Criminalization of self-managed abortion and protecting medical privacy

Unnecessary reports to police by medical providers are a key pathway to the criminalization of people who self-manage abortion care. This panel will discuss findings from research into investigations/arrests of people related to self-management, highlight the harms of criminalization, and clarify that medical professionals need never report self-managed abortion.

3:45 pm-4:15 pm 

Snack break with exhibitors 

Concurrent block V

4:15 pm-5:15 pm

Daniel R. Mishell, Jr. outstanding article awards

  • The association between state-level abortion restrictions and maternal mortality in the United States, 1995-2017 
  • Ectopic pregnancy prevention: Further evidence of benefits of prescription contraceptives 
  • Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation 

 

4:15 pm-5:15 pm

Be a change maker: Using implementation science approaches to improve family planning research

The strategic generation, translation and use of evidence, implementation science (IS) can promote the uptake of evidence-based practices. In this workshop, IS scientists will lead interactive conversations about IS, present real-world case examples of using IS in family planning programming, and discuss how to incorporate IS principles in family planning projects.

4:15 pm-5:15 pm

Synthesizing values and preferences for contraceptive methods: Systematic reviews to inform World Health Organization guidelines

This session presents findings from a series of systematic reviews of the published literature on contraception values and preferences among a diverse range of populations. These reviews were conducted to inform the World Health Organization guideline development process for several recent contraception guidelines.

4:15 pm-5:15 pm

Delivering high quality, equitable abortion care in the emergency department: Creating cross-professional collaboration

Optimal post-abortion care requires collaboration between reproductive health and emergency medicine providers. This interactive session with a panel of family planning physicians, emergency physicians, and Ryan Residency Program administrators will provide strategies for engaging emergency medicine colleagues to improve care for people with recent abortions.

4:15 pm-5:15 pm

Providing mifepristone in Federally Qualified Health Centers

Federally Qualified Health Centers (FQHCs) can provide mifepristone for medication abortion and early pregnancy loss but many barriers exist. We will describe three programs supporting FQHCs to add mifepristone services and share examples of successful implementation. We will discuss common hurdles in FQHCs and strategies to overcome them.

Plenary

5:30 pm-6:40 pm 

Awards presentation
Unaccredited session

6:45 pm-8:15 pm

National Abortion Federation members reception
Invitation only

7:15 pm-9:15 pm

Complex Family Planning Fellowship reception

 [Back to top]

Monday, December 5

Concurrent block VI

7:45 am-8:45 am

#WeCount: Shifts in abortion volumes in a post-Dobbs landscape

#WeCount is a national abortion reporting effort aimed at capturing state-level shifts in abortion volume post-Dobbs. Panelists will present findings from data reported in the months immediately following the Dobbs ruling and explore the impact of these shifts on abortion access and policy strategies.

9:00 am-10:00 am

Clinicians as abortion advocates: Lessons learned from two clinician advocacy training programs

Abortion advocacy is especially important given threats to abortion legality and best practices around advocacy training for clinicians have not been established. We combine findings from an advocacy training evaluation with lived experiences of advocates to discuss skills needed, what it means to be a clinician-advocate, and facilitators/barriers to advocacy.

9:00 am-10:00 am

Next-generation contraception - where would you invest your money?

With limited resources, funders must select which contraceptives merit investment. Three contraceptive developers will propose: What is the biggest impact you could make if you had $100 million over the next decade? Our shark tank will critique their vision and highlight key questions challenging contraceptive research and development.

9:00 am-10:00 am

Misinformation about the mechanism of action of emergency contraception: The stakes for access and policy

With half of the US poised to ban abortion, emergency contraception will be an increasingly important strategy for pregnancy prevention. Access to EC is limited in part by confusion about its mechanism of action. This panel describes the widespread misconstrual of how emergency contraception works and the potential impact on policy and access.

9:00 am-10:00 am

Is less more? A critical reappraisal of medication abortion follow-up

Medication abortion follow-up is idiosyncratic, determined by guidelines, reimbursement, laws, and concern for client wellbeing. Available options, including ultrasound, serum-hCG levels, pregnancy tests, and symptom evaluation all have advantages and limitations, and one size does not fit all. Client preferences, risk perception, emerging technologies, and post-Roe considerations will be explored.

9:00 am-10:00 am 

Anticipating barriers to adolescent abortion access: Research and advocacy

Young people, especially minors less than 18, will be disproportionally affected by restricted abortion access. This symposium highlights work by SFP members and partners in advocacy and other professional organizations to elevate the additional challenges to abortion access that adolescents will face and advocate for adolescent abortion access in this changing landscape.

10:00 am-10:30 am 

Networking break with exhibitors 

Plenary

10:30 am-10:35 am

Announcement of research presentation awards

10:35 am-11:45 am

Collateral damage: Graduate Medical Education in a post-Dobbs US

Our panel of trainees, faculty, and administrators will delve into abortion care training in a post-Dobbs US, including navigating and mentoring for the residency Match and ACGME requirements, recruiting and retaining Complex Family Planning clinician-educators in hostile states, and training traveling residents in haven states, including non-academic settings.

11:45 am-12:00 pm

Closing remarks

12:15 pm-2:15 pm

Contraception journal lunch
Invitation only

Note: times, topics, and speakers may shift as we build the best possible schedule for you. 
[Back to top]

Poster list 2022

Abortion P1 – P54 

  • P001: Telehealth or in-clinic medication abortion care: How patients choose between care options - Anna Fiastro, MPH, MEM, PhDc

  • P002: Abortion pills for future use: Who is receiving advanced provision of medications to induce abortion - Anna Fiastro, MPH, MEM, PhDc

  • P003: We are completely captured: The influence of US foreign policy through the Global Gag Rule on Malawi's sexual and reproductive health and rights landscape - Aishwarya Iyer, MPH

  • P004: Unmet need for abortion: Conceptualization, relevance, and utility as a tool for meeting abortion needs in the US - Ariana Bennett, DrPH, MPH

  • P005: Effect of Medicaid coverage on administration of anesthesia during abortion procedures: An interrupted time series analysis - Cassandra Kelly, MD

  • P006: Canadian newspapers support mifepristone introduction for medication abortion to improve the right to health (2015-2019) - Pallavi Sriram, MD

  • P007: Accuracy of self-assessment of pregnancy duration eligibility for medication abortion among young people: The advantages of expanding screening questions beyond date of last menstrual period - Lauren Ralph, PhD, MPH

  • P008: Information on medication abortion provided by family planning clinics in California - Sophia Kawamoto, BA

  • P009: Nurse practitioner prescribing of mifepristone in Canada - Martha Paynter, PhD

  • P010: Healthcare at the margins: The role of healthcare providers in self-managed abortion near the US-Mexico border - Kathleen Broussard, PhD

  • P011: Impact of Texas 2020 executive order on abortion access and wait times - Brooke N. Whitfield, MA

  • P012: Acceptability of self-managed medication abortion using misoprostol-alone provided via a hybrid telemedicine and pharmacy pick-up model in the US - Dana M. Johnson, MPAff

  • P013: Abortion training preferences of applicants to obstetrics and gynecology residency programs - Elena Perkins, MD

  • P014: Evaluating abortion cash-pay availability during the early COVID-19 pandemic: Data from a nationwide survey of abortion providers - Luisa Silva, MPH

  • P015: Acculturative processes in the generation and evolution of family planning stigma: Lessons from the Los Angeles Filipinx/a/o Family Planning Study - Katrina Heyrana, MD, PhD

  • P016: Experiences of self-managed abortion in Indiana: Financial barriers to clinical care and a need for information on self-managed medication abortion - Heidi Moseson, PhD, MPH

  • P017: Experiences of Indiana residents who traveled out of state to obtain abortion care: The role of abortion funds in restrictive states - Heidi Moseson, PhD, MPH

  • P018: Defining hemorrhage using modified quantitative blood loss in abortion patients - Cassandra Gilbert, BA

  • P019: Illinois patient experiences with public and private insurance coverage for abortion following policy change - Lee Hasselbacher, JD

  • P020: Exploring pharmacist comfort and readiness to dispense mifepristone - Lee Hasselbacher, JD

  • P021: National levels of support for legalizing and not criminalizing people involved in self-managed abortion (SMA): A national representative survey - M. Antonia Biggs, PhD

  • P022: Growing national interest and support for advance provision and over-the-counter access to medication abortion - M. Antonia Biggs, PhD

  • P023: Adaptations to COVID: Analysis of national abortion clinic survey data - Jessica Chen, MD

  • P024: Doulas do need to be there to support if they choose to have an abortion: Family planning attitudes and stigma among doulas in Georgia - Alyssa Lindsey, MPH

  • P025: Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment - Daniel Grossman, MD

  • P026: Out-of-state abortion training: Experiences from Texas - Jema Turk, PhD, MPA, MA

  • P027: Abortion complexity and abortion identity: Findings from the Ohio Survey of Women - Mikaela Smith, PhD

  • P028: Mandatory delay periods and patient access to medication abortion - Sarah Hershberger, BS

  • P029: Barriers to abortion and timing of presentation for care - Jennifer Alison Mackinnon Krems, BA

  • P030: Interest in Rh testing and Rho(D) immune globulin received among patients obtaining first-trimester medication abortion through virtual clinics - Linda Shin, BA

  • P031: Mifepristone as a normal prescription rapidly increased rural and urban providers - Wendy Norman, MD

  • P032: COVID-19 abortion experiences on Reddit: A qualitative study - Laura Jacques, MD

  • P033: Patient acceptability of asynchronous vs synchronous telehealth medication abortion care in the US - Leah Koenig, MSPH

  • P034: Who fails to obtain abortion care in Indiana? Results from a longitudinal, online survey - Alexandra Wollum, MPH

  • P035: No test medication abortion: A systematic review - Marit Pearlman Shapiro, MD, MPH

  • P036: Exploring US obstetrician-gynecologists characterization of periviable pregnancy-ending interventions: A mixed methods study - Rachel Flink-Bochacki, MD, MPH

  • P037: Indicators of the consequences of parental involvement laws illustrate the extent of need for and denials of judicial bypass post-Roe implications - Amanda Stevenson, PhD

  • P040: You're on your own: A qualitative analysis of Texas Senate Bill 8 on abortion care in patients with lethal or life-limiting fetal diagnoses - Courtney Baker, MD, MPH

  • P042: Early pregnancy loss medical management in clinical practice after mifepristone-misoprostol clinical trial - Courtney Baker, MD, MPH

  • P043: Southern health providers perspectives on policy considerations for implementation of telehealth medication abortion services - Subasri Narasimhan, PhD, MPH

  • P044: Maximizing available resources to increase medication abortion access in restricted legal environments: Lessons from Rwanda - Ndola Prata, MD, MSc

  • P045: Sexual orientation among a national sample of people obtaining abortions in 2021-2022 - Doris Chiu, BA

  • P046: Impact of birthing volumes on abortion provision and surgical miscarriage management - Ivana Thompson, MD, MSCI

  • P047: Physician beliefs about abortion safety and their participation in abortion care - Laura E. T. Swan, PhD, LCSW

  • P048: Risk of uterine rupture in second-trimester medication abortions using mifepristone and misoprostol after cesarean birth: A systematic review and meta-analysis - Andrea Henkel, MD, MS

  • P049: Characterizing physician concerns with publicly supporting abortion - Abigail Cutler, MD, MPH

  • P050: Predictors of severe pain during medication abortion at ≤9 weeks gestation: A secondary analysis of a multicenter, randomized, placebo-controlled trial - Kelsey Loeliger, MD, PhD

  • P051: Understanding medication abortion denial among a cohort of abortion clinic patients in Southern California - Kellie Schueler, MD

  • P052: I feel like I had the best team: Patients experiences with telehealth abortion in primary care - Silpa Srinivasulu, MPH

  • P053: I totally didn't need to be there in person: Women's receptivity to telehealth visits for sexual and reproductive health in primary care - Silpa Srinivasulu, MPH

  • P054: Medication abortion via telemedicine: Interest among young people in Texas and California - Cynthia Harper, PhD

 Contraception P55 – P86 

  • P055: Contraceptive use among Medicare enrollees with a disability - Jacqueline Ellison, PhD, MPH

  • P056: Oral contraceptive adherence and pregnancy rates in estetrol/drospirenone pooled phase 3 trials - Mitchell Creinin, MD

  • P057: Levonorgestrel 52 mg intrauterine system efficacy and safety after eight years of use - Beatrice Chen, MD, MPH

  • P058: TikTok and #IUD: The user experience with intrauterine devices on social media - Jenny Wu, MD

  • P059: Pharmacodynamic evaluation of the etonogestrel contraceptive implant initiated midcycle with and without ulipristal acetate: A pilot randomized controlled trial - Lori Gawron, MD, MPH

  • P060: Utilization of LARC methods at the time of emergency contraception visit: A prospective observational study - Lori Gawron, MD, MPH

  • P061: Sterilization in the childfree population: An exploratory study - Ashley Parker, MS

  • P062: Underage and unprotected: Assessing minors ability to obtain confidential contraception in Washington DC - Maya Or, MD

  • P063: Association between postpartum contraceptive use and postpartum depression at 12 months - Rachel Paul, MPH

  • P064: Depression after 12-month use of oral or intrauterine contraception - Rachel Paul, MPH

  • P065: Long acting reversible contraceptive (LARC) insertions in 2019 in the states with most restrictive and trigger abortion policies - Simone Crespi, MPH

  • P066: Using an adult mindset: An examination of fertility desires and reproductive planning among low-income Black fathers. - Adaobi Anakwe, PhD. MPH, CHES

  • P067: Understanding the family planning decision-making choices of people who inject drugs - Tejasvi Gowda, MD

  • P068: Navigating uncertainty: (In)fertility and reproductive planning - Alison Norris, MD, PhD

  • P069: Adolescent patients' comfort discussing contraception: Comparing physicians' perceptions and adolescents' self-reported preferences - Alma Lopez, BS

  • P070: Short-interval births among patients choosing immediate postpartum long-acting reversible contraception (IPP LARC) after Tennessee Medicaid policy change - Nikki Zite, MD, MPH

  • P071: Men's willingness to use novel male contraception is linked to gender equitable attitudes - Tamar Jacobsohn, BA

  • P072: Preferred contraceptive use and barriers to care in Mississippi - Amanda Nagle, MPH

  • P073: Contraceptive uptake amongst gender-expansive individuals in the HER Salt Lake Contraceptive Initiative - Evangelia Lazaris, MD, MS

  • P074: Care about me as a human: Building affirming relationships with transgender and gender-expansive patients - Paige Varin, BA

  • P075: Implementation of pharmacy access to hormonal contraception - Lindsay Dale, MD

  • P076: Contraceptive use by females with chronic medical conditions in a large integrated healthcare system - Katharine Sznajder, MD, MPH

  • P077: Pilot study on a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant - Cara Clure, MD, MSCS

  • P078: Use of direct-to-consumer telemedicine companies for contraception among young adults - Jennifer Yarger, PhD

  • P079: Etonogestrel contraceptive implant users can experience breakthrough ovulation with only two weeks of exposure to a strong CYP3A inducer - Aaron Lazorwitz, MD, MSCS

  • P080: Telehealth visits for contraception during the COVID-19 pandemic: A national survey - Allison A. Merz, MD

  • P081: And then what happened? Assessing contraceptive use outcomes over three years among participants in the HER Salt Lake contraceptive initiative - Rebecca Simmons, PhD, MPH

  • P082: Rural-urban differences in post-abortion contraception use and past contraceptive access: A cohort study of abortion patients in Utah - Amelia Clement, MD, MSCI

  • P083: The impact of federal and state-level contraceptive coverage policies on contraceptive cost and use among privately insured women - Amy Zheng, BS

  • P084: The role of pediatric subspecialists in adolescent and young adult contraceptive care - Molly Richards, MD

  • P085: Clinicians' perspectives on improving shared decision making during contraceptive counseling: A qualitative study in the US - Rose Goueth, MS

  • P086: Documentation status and contraceptive use among women in California - Angubeen Khan, MPH

 Clinical practice P87 – P93 

  • P087: Medical management of early pregnancy in emergency departments compared to outpatient: Evaluating a COVID-19 institutional policy change to increase healthcare access - Roselle Bleck, MD, MPH

  • P088: Uterine cramping and bleeding in transgender and nonbinary individuals on gender-affirming testosterone therapy - Jeffrey Sobieraj, BS

  • P089: Rh-immunoglobulin administration for patients with first trimester bleeding: Estimating the cost to the healthcare system - Emma Gilmore, MD

  • P090: Perceptions of HIV risk screening strategies among patients seeking abortion, contraception, and pregnancy loss management - Sarita Sonalkar, MD, MPH

  • P091: Impact of adverse childhood experiences, anxiety, and resilience on pain during office manual uterine aspiration - Allison Shaber, MD

  • P092: Measuring utilization of mifepristone in medication management of missed abortions: Retrospective claims analysis study - Elise Boos, MD, MSc

  • P093: Patient-centered metrics for quality of reproductive health care - Meredith Manze, MPH, PhD

 Training/education P94 – P97 

  • P094: Sexual and reproductive health advocacy successes, failures, and needs in the US: Perspectives from key stakeholders - Meredith Manze, MPH, PhD

  • P095: Let's Chat: Initial feasibility, usability, and acceptability of a novel adolescent-centered sexual and reproductive care web-based app - Amanda Geppert, CPhil, MPH

  • P096: Nexplanon training: Knowledge, experience and perspectives among family medicine residents and preceptors in New Jersey - Stephanie Mischell, MD

  • P097: Resident initiated obstetrics and gynecology didactics as a method of keeping up with the evolving abortion legislative landscape - Jayne Caron, MD

 Other P98 – P100 

  • P098: Interest in late period pills in the US: A nationally representative survey - Ushma Upadhyay, PhD, MPH

  • P099: Statewide changes in service trends at Utah Title X clinics around the Domestic Gag Rule, 2017-2021 - Alexandra Gero, MPH

  • P100: Stigma and social norms as drivers of partner support during pregnancy decision-making: Results of a focus group study among cisgender men - Alischer Cottrill, MPH

 [Back to top]